Product portfolio

Liquid biopsy

See clearly, understand more

Liquid biopsy was not always an option for molecular laboratories due to the short 4-hour window from blood collection to cfDNA extraction, time intensive workflows, and the need for specific technical expertise.

From sample collection, polymerase chain reaction (PCR) testing, and next-generation sequencing (NGS)—Roche’s robust liquid biopsy portfolio is bringing new possibilities to clinical research and diagnostics.

Lab technician


Created for easy adoption

From simple PCR workflows to the turnkey NGS kit-based solution, the Roche Liquid Biopsy portfolio facilitates in-house adoption of liquid biopsy testing.

  • cfDNA collection
  • Tumor profiling
  • Surveillance for minimal residual disease - RUO
  • Longitudinal monitoring for tumor burden - RUO
illustration of blood stream


Designed to meet high quality Roche standards

  • Collection tubes providing a high degree of stability to prevent cell lysis up to 8 hours
  • Reliable PCR assays backed by robust clinical evidence
  • Ultra-sensitive NGS ctDNA tumor profiling, surveillance and monitoring assays that are purpose-built for liquid biopsy research
  • Sample stability in transit and at different temperatures
  • PCR assays run on the trusted cobas® platform
  • Fully supported by Roche’s leading service, logistics and distribution network
A deep dive into liquid biopsy

Download this scientific summary on how comprehensive genomic profiling of liquid biopsies could facilitate personalised healthcare in oncology.

illustration of blood stream
Doing now what patients need next

As the intricacies of cancer become better understood, new discoveries will follow.

From uncovering the next major breakthrough to monitoring for disease progression, the Roche liquid biopsy portfolio can help make your vision of personalized patient care a reality.

Download a scientific summary on liquid biopsy

Form Successfully Submitted!
Thank you for your submission!
Roche BRAF/NRAS kit

BRAF/NRAS Mutation Test (LSR)

Qualitative detection and identification of mutations in the BRAF gene and the NRAS viral oncogenes.

Learn more
Roche BRAF/NRAS kit

KRAS Mutation Test v2 (LSR)

Qualitative detection and identification of 28 mutations in exons 2, 3, and 4 of the KRAS gene.

Learn more
cobas EGFR

cobas® EGFR Mutation Test v2

A companion diagnostic test to identify 42 mutations in the EGFR gene, including the T790M resistance mutation.


AVENIO ctDNA Analysis Kits (RUO)

A portfolio of assay kits – all set and ready for you to use for tumor profiling and surveillance & monitoring.

Learn more

AVENIO ctDNA Analysis Kits, Roche/AVENIO NGS liquid biopsy assays, BRAF/NRAS Mutation Test, KRAS Mutation Test v2, and the RUO version of the Roche Cell-Free DNA Collection Tube are For Research Use Only, and not for use in diagnostic procedures.

RUO: Research Use Only
LSR: Life Science Research

Found 0 results in